• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将成肌细胞和脂肪来源的间充质干细胞子宫内移植到杜氏肌营养不良症小鼠模型中,不会导致细胞植入,且常常导致胎儿死亡。

In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death.

作者信息

Kihara Yuki, Tanaka Yukie, Ikeda Masanari, Homma Jun, Takagi Ryo, Ishigaki Keiko, Yamanouchi Keitaro, Honda Hiroaki, Nagata Satoru, Yamato Masayuki

机构信息

Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan.

Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan.

出版信息

Regen Ther. 2022 Oct 20;21:486-493. doi: 10.1016/j.reth.2022.10.003. eCollection 2022 Dec.

DOI:10.1016/j.reth.2022.10.003
PMID:36313392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9596598/
Abstract

INTRODUCTION

Duchenne muscular dystrophy (DMD) is a progressive disease that leads to damage of muscle and myocardium due to genetic abnormalities in the dystrophin gene. In utero cell transplantation that might facilitate allogenic transplantation is worth considering to treat this disease.

METHODS

We performed allogeneic in utero transplantation of GFP-positive myoblasts and adipose-derived mesenchymal stem cells into murine DMD model animals. The transplantation route in this study was fetal intraperitoneal transplantation and transplacental transplantation. Transplanted animals were examined at 4-weeks old by immunofluorescence staining and RT-qPCR.

RESULTS

No GFP-positive cells were found by immunofluorescence staining of skeletal muscle and no GFP mRNA was detected by RT-qPCR in any animal, transplantation method and cell type. Compared with previous reports, myoblast transplantation exhibited an equivalent mortality rate, but adipose-derived stem cell (ASC) transplantation produced a higher mortality rate.

CONCLUSIONS

In utero transplantation of myoblasts or ASCs to murine models of DMD does not lead to engraftment and, in ASC transplantation primarily, frequently results in fetal death.

摘要

引言

杜氏肌营养不良症(DMD)是一种进行性疾病,由于肌营养不良蛋白基因的遗传异常导致肌肉和心肌受损。子宫内细胞移植可能有助于同种异体移植,值得考虑用于治疗这种疾病。

方法

我们将绿色荧光蛋白(GFP)阳性的成肌细胞和脂肪来源的间充质干细胞同种异体移植到小鼠DMD模型动物的子宫内。本研究中的移植途径是胎儿腹腔内移植和经胎盘移植。对移植后的动物在4周龄时进行免疫荧光染色和逆转录定量聚合酶链反应(RT-qPCR)检测。

结果

在任何动物、移植方法和细胞类型中,通过骨骼肌的免疫荧光染色均未发现GFP阳性细胞,RT-qPCR也未检测到GFP mRNA。与先前的报道相比,成肌细胞移植的死亡率相当,但脂肪来源干细胞(ASC)移植的死亡率更高。

结论

将成肌细胞或ASC子宫内移植到DMD小鼠模型中不会导致植入,主要是在ASC移植中,经常导致胎儿死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/df0a9ae2ebc5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/e2b1e2d38d73/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/48b868b8ff4e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/df0a9ae2ebc5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/e2b1e2d38d73/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/48b868b8ff4e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be8/9596598/df0a9ae2ebc5/gr3.jpg

相似文献

1
In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death.将成肌细胞和脂肪来源的间充质干细胞子宫内移植到杜氏肌营养不良症小鼠模型中,不会导致细胞植入,且常常导致胎儿死亡。
Regen Ther. 2022 Oct 20;21:486-493. doi: 10.1016/j.reth.2022.10.003. eCollection 2022 Dec.
2
[Mice adipose derived Flk-1+ mesenchymal stem cells can ameliorate Duchenne's muscular dystrophy in Mdx mice for their multilineage potential].[小鼠脂肪来源的Flk-1+间充质干细胞因其多向分化潜能可改善Mdx小鼠的杜氏肌营养不良症]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Apr;15(2):306-12.
3
Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.人多能脂肪来源干细胞在体外恢复杜氏骨骼肌细胞的肌营养不良蛋白表达。
Biol Cell. 2008 Apr;100(4):231-41. doi: 10.1042/BC20070102.
4
Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.使用磷酸二酯酶抑制剂异丁基甲基黄嘌呤诱导CCAAT/增强子结合蛋白β表达可改善成肌细胞向营养不良性肌肉的植入。
Stem Cells Transl Med. 2016 Apr;5(4):500-10. doi: 10.5966/sctm.2015-0169. Epub 2016 Mar 3.
5
Beneficial role of adipose-derived mesenchymal stem cells from microfragmented fat in a murine model of duchenne muscular dystrophy.微粉碎脂肪来源的脂肪间充质干细胞在杜氏肌营养不良症小鼠模型中的有益作用。
Muscle Nerve. 2019 Sep;60(3):328-335. doi: 10.1002/mus.26614. Epub 2019 Jul 16.
6
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.系统性移植表达抗肌萎缩蛋白嵌合(DEC)细胞后对 mdx 小鼠模型杜氏肌营养不良症的心脏保护作用。
Stem Cell Rev Rep. 2019 Dec;15(6):827-841. doi: 10.1007/s12015-019-09916-0.
7
Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.肌母细胞来源的表达抗肌萎缩蛋白嵌合细胞的构建:一种新型基于干细胞的杜氏肌营养不良症治疗方法。
Stem Cell Rev Rep. 2018 Apr;14(2):189-199. doi: 10.1007/s12015-017-9792-7.
8
Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.胎盘源间充质基质细胞及其外泌体在杜氏肌营养不良症中发挥治疗作用。
Biomaterials. 2018 Aug;174:67-78. doi: 10.1016/j.biomaterials.2018.04.055. Epub 2018 May 3.
9
[Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].[脐带血干细胞移植治疗杜氏肌营养不良症]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Aug;22(4):399-405.
10
Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.人源抗肌萎缩蛋白嵌合(DEC)细胞疗法改善杜氏肌营养不良症的心脏、呼吸和骨骼肌功能。
Stem Cells Transl Med. 2021 Oct;10(10):1406-1418. doi: 10.1002/sctm.21-0054. Epub 2021 Jul 22.

引用本文的文献

1
Fetal-to-fetal kidney transplantation in utero.子宫内胎儿间肾移植
Commun Biol. 2025 Mar 3;8(1):349. doi: 10.1038/s42003-025-07783-9.

本文引用的文献

1
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.晚期杜氏肌营养不良症重复静脉注射心脏球衍生细胞治疗(HOPE-2):一项多中心、随机、双盲、安慰剂对照的2期试验。
Lancet. 2022 Mar 12;399(10329):1049-1058. doi: 10.1016/S0140-6736(22)00012-5.
2
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience.维托拉森治疗杜氏肌营养不良症的药理学概况:日本经验
Clin Pharmacol. 2021 Dec 16;13:235-242. doi: 10.2147/CPAA.S288842. eCollection 2021.
3
Systemic Supplementation of Collagen VI by Neonatal Transplantation of iPSC-Derived MSCs Improves Histological Phenotype and Function of Col6-Deficient Model Mice.
通过诱导多能干细胞衍生的间充质干细胞的新生儿移植进行系统性胶原蛋白VI补充可改善Col6缺陷模型小鼠的组织学表型和功能。
Front Cell Dev Biol. 2021 Nov 23;9:790341. doi: 10.3389/fcell.2021.790341. eCollection 2021.
4
Wharton's Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499.源自华通氏胶的间充质干细胞通过上调微小RNA 499减轻杜氏肌营养不良小鼠模型中的纤维化。
Biomedicines. 2021 Aug 26;9(9):1089. doi: 10.3390/biomedicines9091089.
5
Generation of reconstituted hemato-lymphoid murine embryos by placental transplantation into embryos lacking HSCs.通过胎盘移植到缺乏造血干细胞的胚胎中生成重组血淋巴胚胎。
Sci Rep. 2021 Feb 23;11(1):4374. doi: 10.1038/s41598-021-83652-9.
6
Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy.细胞衰老介导的杜氏肌营养不良症恶化。
Sci Rep. 2020 Oct 12;10(1):16385. doi: 10.1038/s41598-020-73315-6.
7
Muscular dystrophies.肌肉萎缩症。
Lancet. 2019 Nov 30;394(10213):2025-2038. doi: 10.1016/S0140-6736(19)32910-1.
8
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.系统性移植表达抗肌萎缩蛋白嵌合(DEC)细胞后对 mdx 小鼠模型杜氏肌营养不良症的心脏保护作用。
Stem Cell Rev Rep. 2019 Dec;15(6):827-841. doi: 10.1007/s12015-019-09916-0.
9
Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives.血管内间充质干细胞治疗引起的血栓形成风险:现状与未来展望。
Cells. 2019 Sep 27;8(10):1160. doi: 10.3390/cells8101160.
10
Allogeneic adipose-derived mesenchymal stem cell sheet that produces neurological improvement with angiogenesis and neurogenesis in a rat stroke model.异体脂肪来源间充质干细胞片在大鼠中风模型中通过血管生成和神经发生产生神经改善作用。
J Neurosurg. 2019 Feb 22;132(2):442-455. doi: 10.3171/2018.11.JNS182331. Print 2020 Feb 1.